Downregulation of p21(WAF1/CIP1) and estrogen receptor α in MCF-7 cells by antisense oligonucleotides containing locked nucleic acid (LNA)

被引:19
作者
Jepsen, JS
Pfundheller, HM
Lykkesfeldt, AE
机构
[1] Danish Canc Soc, Dept Tumor Endocrinol, Inst Canc Biol, DK-2100 Copenhagen, Denmark
[2] Exiqon AS, DK-2950 Vedbaek, Denmark
关键词
D O I
10.1089/1545457041526281
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Locked nucleic acid (LNA) is a nucleic acid analog with very high affinity to complementary RNA and a promising compound in the field of antisense research. The intracellular localization and quantitative uptake of oligonucleotides containing LNA were found to be equivalent to those of phosphorothioate oligonucleotides (PS AONs). The antisense efficiency of LNA-containing oligonucleotides was systematically compared with standard PS AONs targeting expression of two endogenous proteins in the human breast cancer cell line MCF-7, namely, the cyclin-dependent kinase inhibitor p21((wAF1/CIP1)) and the estrogen receptor alpha (ERalpha). For downregulation of both target proteins, the most efficient design was achieved with oligonucleotides containing LNA monomers in the extremities and a central gap of PS-linked DNA monomers, so called LNA gapmers. Such LNA gapmers caused more potent downregulation of the targeted proteins than PS AONs, whereas fully modified LNA AONs or LNA mixmers (LNA nucleotides interspersed) were inactive.
引用
收藏
页码:147 / 156
页数:10
相关论文
共 41 条
[1]   Tolerance for mutations and chemical modifications in a siRNA [J].
Amarzguioui, M ;
Holen, T ;
Babaie, E ;
Prydz, H .
NUCLEIC ACIDS RESEARCH, 2003, 31 (02) :589-595
[2]   Oligonucleotide analogue interference with the HIV-1 Tat protein-TAR RNA interaction [J].
Arzumanov, A ;
Walsh, AP ;
Liu, XH ;
Rajwanshi, VK ;
Wengel, J ;
Gait, MJ .
NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS, 2001, 20 (4-7) :471-480
[3]   Inhibition of HIV-1 Tat-dependent trans activation by steric block chimeric 2′-O-methyl/LNA oligoribonucleotides [J].
Arzumanov, A ;
Walsh, AP ;
Rajwanshi, VK ;
Kumar, R ;
Wengel, J ;
Gait, MJ .
BIOCHEMISTRY, 2001, 40 (48) :14645-14654
[4]   A SERIES OF 14 NEW MONOCLONAL-ANTIBODIES TO KERATINS - CHARACTERIZATION AND VALUE IN DIAGNOSTIC HISTOPATHOLOGY [J].
BARTEK, J ;
VOJTESEK, B ;
STASKOVA, Z ;
BARTKOVA, J ;
KEREKES, Z ;
REJTHAR, A ;
KOVARIK, J .
JOURNAL OF PATHOLOGY, 1991, 164 (03) :215-224
[5]   RNA interference in mammalian cells by chemically-modified RNA [J].
Braasch, DA ;
Jensen, S ;
Liu, YH ;
Kaur, K ;
Arar, K ;
White, MA ;
Corey, DR .
BIOCHEMISTRY, 2003, 42 (26) :7967-7975
[6]   Antisense inhibition of gene expression in cells by oligonucleotides incorporating locked nucleic acids: effect of mRNA target sequence and chimera design [J].
Braasch, DA ;
Liu, YH ;
Corey, DR .
NUCLEIC ACIDS RESEARCH, 2002, 30 (23) :5160-5167
[7]   Down-regulation of p21WAF1/CIP1 or p27Kip1 abrogates antiestrogen-mediated cell cycle arrest in human breast cancer cells [J].
Cariou, S ;
Donovan, JCH ;
Flanagan, WM ;
Milic, A ;
Bhattacharya, N ;
Slingerland, JM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (16) :9042-9046
[8]  
Chen Helen X, 2003, Methods Mol Med, V75, P621
[9]  
CROOKE ST, 2002, METHOD ENZYMOL, V313, P3
[10]   Structural variations and stabilising modifications of synthetic siRNAs in mammalian cells [J].
Czauderna, F ;
Fechtner, M ;
Dames, S ;
Aygün, H ;
Klippel, A ;
Pronk, GJ ;
Giese, K ;
Kaufmann, J .
NUCLEIC ACIDS RESEARCH, 2003, 31 (11) :2705-2716